Literature DB >> 29865069

Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.

Solveig Tiepolt1, Andreas Schäfer2,3, Michael Rullmann1,2, Elisabeth Roggenhofer2,4, Hermann-Josef Gertz5, Matthias L Schroeter2,6, Marianne Patt1, Pierre-Louis Bazin2, Thies H Jochimsen1, Robert Turner2, Osama Sabri1, Henryk Barthel1.   

Abstract

BACKGROUND: PET imaging is an established technique to detect cerebral amyloid-β (Aβ) plaques in vivo. Some preclinical and postmortem data report an accumulation of redox-active iron near Aβ plaques. Quantitative susceptibility mapping (QSM) at high-field MRI enables iron deposits to be depicted with high spatial resolution.
OBJECTIVE: Aim of this study was to examine whether iron and Aβ plaque accumulation is related and thus, whether 7T MRI might be an additive diagnostic tool to Aβ PET imaging.
METHODS: Postmortem human Alzheimer's disease (AD) and healthy control (HC) frontal gray matter (GM) was imaged with 7T MRI which resulted in T1 maps and QSM. Aβ plaque load was determined by histopathology. In vivo, 10 Aβ PET-positive AD patients (74.1±6.0a) and 10 Aβ PET-negative HCs (67.1±4.4a) underwent 7T MR examination and QSM maps were analyzed. Severity of cognitive deficits was determined by MMSE.
RESULTS: Postmortem, the susceptibility of Aβ plaque-containing GM were higher than those of Aβ plaque-free GM (0.011±0.002 versus - 0.008±0.003 ppm, p < 0.001). In vivo, only the bilateral globus pallidus showed significantly higher susceptibility in AD patients compared to HCs (right: 0.277±0.018 versus - 0.009±0.009 ppm; left: 0.293±0.014 versus - 0.007±0.012 ppm, p < 0.0001). The pallidal QSM values were negatively correlated with those of the MMSE (r = - 0.69, p = 0.001).
CONCLUSION: The postmortem study revealed significant susceptibility differences between the Aβ plaque-containing and Aβ plaque-free GM, whereas in vivo only the QSM values of the globus pallidus differed significantly between AD and HC group. The pallidal QSM values correlated with the severity of cognitive deficits. These findings encourage efforts to optimize the 7T-QSM methodology.

Entities:  

Keywords:  7T MRI; Alzheimer’s disease; amyloid; iron accumulation; quantitativezzm321990susceptibility mapping

Mesh:

Substances:

Year:  2018        PMID: 29865069     DOI: 10.3233/JAD-180118

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

Review 1.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

2.  QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping.

Authors:  Ashley Wilton Stewart; Simon Daniel Robinson; Kieran O'Brien; Jin Jin; Georg Widhalm; Gilbert Hangel; Angela Walls; Jonathan Goodwin; Korbinian Eckstein; Monique Tourell; Catherine Morgan; Aswin Narayanan; Markus Barth; Steffen Bollmann
Journal:  Magn Reson Med       Date:  2021-10-22       Impact factor: 4.668

Review 3.  Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?

Authors:  Farzaneh Nikparast; Zohreh Ganji; Hoda Zare
Journal:  BMC Neurosci       Date:  2022-07-28       Impact factor: 3.264

4.  Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals.

Authors:  Gloria C Chiang; Junghun Cho; Jonathan Dyke; Hang Zhang; Qihao Zhang; Michael Tokov; Thanh Nguyen; Ilhami Kovanlikaya; Michael Amoashiy; Mony de Leon; Yi Wang
Journal:  J Neuroimaging       Date:  2022-03-16       Impact factor: 2.324

5.  Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study.

Authors:  Gregory Brown; Guangwei Du; Elana Farace; Mechelle M Lewis; Paul J Eslinger; James McInerney; Lan Kong; Runze Li; Xuemei Huang; Sol De Jesus
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

6.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 7.  Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?

Authors:  Farzaneh Nikparast; Zohreh Ganji; Mohammad Danesh Doust; Reyhane Faraji; Hoda Zare
Journal:  Insights Imaging       Date:  2022-04-13

8.  Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.

Authors:  Petrice M Cogswell; Heather J Wiste; Matthew L Senjem; Jeffrey L Gunter; Stephen D Weigand; Christopher G Schwarz; Arvin Arani; Terry M Therneau; Val J Lowe; David S Knopman; Hugo Botha; Jonathan Graff-Radford; David T Jones; Kejal Kantarci; Prashanthi Vemuri; Bradley F Boeve; Michelle M Mielke; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2020-10-06       Impact factor: 6.556

9.  Magnetic domains oscillation in the brain with neurodegenerative disease.

Authors:  Gunther Kletetschka; Robert Bazala; Marian Takáč; Eva Svecova
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 10.  Iron and Alzheimer's Disease: From Pathology to Imaging.

Authors:  Dean Tran; Phillip DiGiacomo; Donald E Born; Marios Georgiadis; Michael Zeineh
Journal:  Front Hum Neurosci       Date:  2022-07-13       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.